Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating Tumor DNA in Cancer Management.

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae - 10 Oct 2016

Li Miao-Zhu, Lin Ian-Zhen, Zhao Hai-Tao

Abstract excerpt

Molecular techniques can be very useful in detecting a patient's tumor to guide treatment decisions is increasingly been applied in the care and management of cancer patients. Circulating tumor DNA (ctDNA) containing mutations can be identified in the plasma of cancer patients during the course of the disease. As a non-invasive "liquid biopsies",ctDNA is a potential surrogate for the entire tumor genome. The use...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm
Share to Mutation
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Prognosis

Share to Reproducibility of Results

Source

Identifiers

PMID: 27825420
DOI: 10.3881/j.issn.1000-503X.2016.05.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating Tumor DNA in Cancer Management.PMID 27825420Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.Semantic proximity Read ↗

Circulating Tumor DNA as a Liquid Biopsy for CancerSemantic proximity Read ↗

[Circulating Tumor DNA in Blood and Its Utilization as a Potential Biomarker for Cancer].Semantic proximity Read ↗

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.Semantic proximity Read ↗

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of CancerSemantic proximity Read ↗

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis.Semantic proximity Read ↗

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection TechniquesSemantic proximity Read ↗

Circulating Tumor DNA: Measurement and Clinical UtilitySemantic proximity Read ↗

The feasibility of using mutation detection in ctDNA to assess tumor dynamics.Semantic proximity Read ↗

ctDNA as a Cancer Biomarker: A Broad OverviewSemantic proximity Read ↗

Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.